For the past month, local basketball programs have teamed up to raise awareness and spread hope for 9-year-old Autumn and ...

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

Ethan Fisher, the son of Texas A&M head football coach Jimbo Fisher, spoke with GigEm247 about his journey with Fanconi anemia, how he got into kicking and his verbal commitment to Samford.

Fanconi anemia (FA) is a rare genetic disorder characterized by defective DNA repair, leading to hematopoietic stem cell (HSC) dysfunction and bone marrow failure. Replication stress, which ...

Patients in the EU with Fanconi anaemia (FA) could soon have the first gene therapy option for the disorder, as the EMA starts a review of Rocket Pharma’s RP-L102 candidate. FA is an inherited ...

The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are exploring innovative approaches ...

Rocket Pharmaceuticals RCKT announced that the EMA accepted the marketing authorization application (MAA), seeking approval for RP-L102, an investigational gene therapy for fanconi anemia (FA).

Fanconi anemia typically manifests in pediatric age, affects the bone marrow stem cells, and is characterized by the progressive loss of blood cells - resulting in serious infections, asthenia ...

Fanconi syndrome is a hereditary or acquired disease of the renal proximal tubules, without primary involvement of kidney glomeruli, and is characterized by the tubular wasting of nutrients and ...

Our work on genomic integrity ranges from the Fanconi Anemia pathway, which responds to DNA interstrand crosslinks, to the ATR and ATM checkpoint kinases that coordinate the cell’s response to ...

Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 22(1):106-16, 7/2012. PMCID: PMC3954744. Siaud N, ...